The decision should be a collaborative one, considering your health goals, response to medications, and personal preferences
Summary: GLP-1/GIP medications help reduce inflammation in metabolic organsnot autoimmune or pain-related inflammation They DO: lower CRP and related metabolic inflammatory/oxidative stress biomarkers, improve metabolic liver disease activity in steatohepatitis settings, improve cardiometabolic risk markers such as blood pressure improve kidney outcomes in high-risk CKD populations (semaglutide
- High purity compound
For example, they might make a liquid version of a drug only available in pill form for a patient who can't swallow pills, or they might replace a non-active ingredient for a patient with an allergy to it
In this comprehensive guide, we will explore exactly what you should anticipate during this crucial timeframe, addressing the physical changes, potential side effects, and milestones you might experience
This type of medicine is primarily used to improve blood glucose control in adults with type 2 diabetes, alongside diet and physical activity